Isolation and Structure of an Antibody that Fully Neutralizes Isolate SIVmac239 Reveals Functional Similarity of SIV and HIV Glycan Shields.


Journal

Immunity
ISSN: 1097-4180
Titre abrégé: Immunity
Pays: United States
ID NLM: 9432918

Informations de publication

Date de publication:
15 10 2019
Historique:
received: 03 12 2018
revised: 20 06 2019
accepted: 11 09 2019
pubmed: 7 10 2019
medline: 18 2 2020
entrez: 7 10 2019
Statut: ppublish

Résumé

HIV- and SIV-envelope (Env) trimers are both extensively glycosylated, and antibodies identified to date have been unable to fully neutralize SIV

Identifiants

pubmed: 31586542
pii: S1074-7613(19)30403-0
doi: 10.1016/j.immuni.2019.09.007
pii:
doi:

Substances chimiques

Antibodies, Monoclonal 0
Antibodies, Neutralizing 0
CD4 Antigens 0
HIV Antibodies 0
HIV Envelope Protein gp120 0
Membrane Glycoproteins 0
Polysaccharides 0
Viral Envelope Proteins 0
gp120 protein, Simian immunodeficiency virus 0

Types de publication

Journal Article Research Support, N.I.H., Intramural Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

724-734.e4

Informations de copyright

Published by Elsevier Inc.

Auteurs

Jason Gorman (J)

Vaccine Research Center, National Institutes of Health, Bethesda, MD 20892, USA.

Rosemarie D Mason (RD)

Vaccine Research Center, National Institutes of Health, Bethesda, MD 20892, USA.

Leonard Nettey (L)

Vaccine Research Center, National Institutes of Health, Bethesda, MD 20892, USA.

Nicole Cavett (N)

Vaccine Research Center, National Institutes of Health, Bethesda, MD 20892, USA.

Gwo-Yu Chuang (GY)

Vaccine Research Center, National Institutes of Health, Bethesda, MD 20892, USA.

Dongjun Peng (D)

Vaccine Research Center, National Institutes of Health, Bethesda, MD 20892, USA.

Yaroslav Tsybovsky (Y)

Electron Microscopy Laboratory, Cancer Research Technology Program, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, MD 21702, USA.

Raffaello Verardi (R)

Vaccine Research Center, National Institutes of Health, Bethesda, MD 20892, USA.

Richard Nguyen (R)

Vaccine Research Center, National Institutes of Health, Bethesda, MD 20892, USA.

David Ambrozak (D)

Vaccine Research Center, National Institutes of Health, Bethesda, MD 20892, USA.

Kristin Biris (K)

Vaccine Research Center, National Institutes of Health, Bethesda, MD 20892, USA.

Celia C LaBranche (CC)

Duke Human Vaccine Institute, Duke University School of Medicine, Duke University, Durham, NC 27710, USA.

Akshaya Ramesh (A)

Boston University School of Medicine, Boston University, Boston, MA 02118, USA.

Chaim A Schramm (CA)

Vaccine Research Center, National Institutes of Health, Bethesda, MD 20892, USA.

Jing Zhou (J)

Vaccine Research Center, National Institutes of Health, Bethesda, MD 20892, USA.

Robert T Bailer (RT)

Vaccine Research Center, National Institutes of Health, Bethesda, MD 20892, USA.

Thomas B Kepler (TB)

Boston University School of Medicine, Boston University, Boston, MA 02118, USA.

David C Montefiori (DC)

Duke Human Vaccine Institute, Duke University School of Medicine, Duke University, Durham, NC 27710, USA.

Lawrence Shapiro (L)

Vaccine Research Center, National Institutes of Health, Bethesda, MD 20892, USA; Department of Biochemistry and Molecular Biophysics, Columbia University, New York, NY 10032, USA.

Daniel C Douek (DC)

Vaccine Research Center, National Institutes of Health, Bethesda, MD 20892, USA.

John R Mascola (JR)

Vaccine Research Center, National Institutes of Health, Bethesda, MD 20892, USA.

Mario Roederer (M)

Vaccine Research Center, National Institutes of Health, Bethesda, MD 20892, USA. Electronic address: roederer@nih.gov.

Peter D Kwong (PD)

Vaccine Research Center, National Institutes of Health, Bethesda, MD 20892, USA. Electronic address: pdkwong@nih.gov.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH